| Pharmacogenetics, drug-metabolizing enzymes, and clinical practice SJ Gardiner, EJ Begg Pharmacological reviews 58 (3), 521-590, 2006 | 553 | 2006 |
| Aminoglycosides--50 years on. EJ Begg, ML Barclay British journal of clinical pharmacology 39 (6), 597, 1995 | 431 | 1995 |
| Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph PA Bird, EJ Begg, M Zhang, AT Keast, DP Murray, TJ Balkany Otology & Neurotology 28 (8), 1124-1130, 2007 | 259 | 2007 |
| Drugs in human milk: clinical pharmacokinetic considerations HC Atkinson, EJ Begg, BA Darlow Clinical pharmacokinetics 14, 217-240, 1988 | 258 | 1988 |
| A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression RL Roberts, PR Joyce, RT Mulder, EJ Begg, MA Kennedy The pharmacogenomics journal 2 (3), 191-196, 2002 | 241 | 2002 |
| A suggested approach to once‐daily aminoglycoside dosing. EJ Begg, ML Barclay, SB Duffull British journal of clinical pharmacology 39 (6), 605-609, 1995 | 231 | 1995 |
| Distribution and excretion of fluoxetine and norfluoxetine in human milk Kristensen, Ilett, Hackett, Yapp, Paech, Begg British journal of clinical pharmacology 48 (4), 521-527, 1999 | 213 | 1999 |
| Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people TJ Wilkinson, EJ Begg, AC Winter, R Sainsbury British journal of clinical pharmacology 47 (2), 211-217, 1999 | 204 | 1999 |
| Prediction of drug distribution into human milk from physicochemical characteristics UC Atkinson, EJ Begg Clinical pharmacokinetics 18, 151-167, 1990 | 171 | 1990 |
| The therapeutic monitoring of antimicrobial agents EJ Begg, ML Barclay, CMJ Kirkpatrick British Journal of Clinical Pharmacology 52 (S1), 35-43, 2001 | 170 | 2001 |
| Free drug metabolic clearance in elderly people JM Butler, EJ Begg Clinical Pharmacokinetics 47, 297-321, 2008 | 162 | 2008 |
| Once daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored? ML Barclay, CMJ Kirkpatrick, EJ Begg Clinical pharmacokinetics 36, 89-98, 1999 | 150 | 1999 |
| Adaptive resistance following single doses of gentamicin in a dynamic in vitro model ML Barclay, EJ Begg, ST Chambers Antimicrobial agents and chemotherapy 36 (9), 1951-1957, 1992 | 150 | 1992 |
| Studying drugs in human milk: time to unify the approach EJ Begg, SB Duffull, LP Hackett, KF Ilett Journal of Human Lactation 18 (4), 323-332, 2002 | 142 | 2002 |
| Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph PA Bird, DP Murray, M Zhang, EJ Begg Otology & Neurotology 32 (6), 933-936, 2011 | 136 | 2011 |
| What is the evidence for once-daily aminoglycoside therapy? ML Barclay, EJ Begg, KG Hickling Clinical pharmacokinetics 27, 32-48, 1994 | 131 | 1994 |
| Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice? SJ Gardiner, EJ Begg Pharmacogenetics and genomics 15 (5), 365-369, 2005 | 119 | 2005 |
| Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants SJ Gardiner, JH Kristensen, EJ Begg, LP Hackett, DA Wilson, KF Ilett, ... American Journal of Psychiatry 160 (8), 1428-1431, 2003 | 118 | 2003 |
| Rapid and simple high-performance liquid chromatographic assay for the determination of metformin in human plasma and breast milk M Zhang, GA Moore, M Lever, SJ Gardiner, CMJ Kirkpatrick, EJ Begg Journal of Chromatography B 766 (1), 175-179, 2002 | 118 | 2002 |
| Distribution of R‐ and S‐methadone into human milk during multiple, medium to high oral dosing EJ Begg, TJ Malpas, LP Hackett, KF Ilett British journal of clinical pharmacology 52 (6), 681-685, 2001 | 117 | 2001 |
